RNA Advisors provides strategic pricing and market access evaluation and planning services over for the full lifecycle of a life sciences or healthcare product. Our work helps early-stage organizations understand and integrate evidence requirements across multiple stakeholders to create brand value. We also assist commercial-stage companies optimize pricing, market access, and reimbursement and contracting opportunities using market-specific evidence, payer goals and competitive threats. We support investors and other stakeholders evaluate pricing and the landscape for market access. We characterize risk and quantify realized net pricing and access levels for purposes of forward-looking forecasts and asset valuations. Additionally, our team provides healthcare policy support to anticipate and plan for policy evolutions in the U.S. and globally.
Members of our expert team have priced many of the most valuable products in our industry’s history, and we work across all major markets, product types and therapy areas.